[Pembrolizumab (Keytruda®) associated ocular hypotony].

Dierse S; Al-Naweiseh S; Esser E; Englmaier V; Eter N; Clemens CR

Research article (journal) | Peer reviewed

Details about the publication

JournalDie Ophthalmologie (Ophthalmologie)
Volume120
Issue10
Page range1042-1044
StatusPublished
Release year2023 (30/10/2023)
Language in which the publication is writtenGerman
KeywordsPembrolizumab; Immuncheckpointinhibitoren; Hypotonia bulbi

Authors from the University of Münster

Al-Nawaiseh, Sami
Clemens, Christoph
Dierse, Sebastian
Englmaier, Verena Anna
Esser, Eliane Luisa
Eter, Nicole